Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence
Abstract
RNA viruses exist as a genetically diverse quasispecies with extraordinary ability to adapt to abrupt changes in the host environment. However, the molecular mechanisms that contribute to their rapid adaptation and persistence in vivo are not well studied. Here, we probe hepatitis C virus (HCV) persistence by analyzing clinical samples taken from subjects who were treated with a second-generation HCV protease inhibitor. Frequent longitudinal viral load determinations and large-scale single-genome sequence analyses revealed rapid antiviral resistance development, and surprisingly, dynamic turnover of dominant drug-resistant mutant populations long after treatment cessation. We fitted mathematical models to both the viral load and the viral sequencing data, and the results provided strong support for the critical roles that superinfection and cure of infected cells play in facilitating the rapid turnover and persistence of viral populations. More broadly, our results highlight the importance of considering viral dynamics and competition at the intracellular level in understanding rapid viral adaptation. Thus, we propose a theoretical framework integrating viral and molecular mechanisms to explain rapid viral evolution, resistance, and persistence despite antiviral treatment and host immune responses.
- Authors:
-
- Department of Mathematics, North Carolina State University, Raleigh, NC 27695,, Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM 87545,
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104,, Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104,
- Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM 87545,, Laboratory of Biomathematics, Faculty of Medicine, University of Lisbon, 1600-276 Lisbon, Portugal,
- Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM 87545,
- Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM 87545,, Santa Fe Institute, Santa Fe, NM 87501,
- Department of Infectious Disease, Merck &, Co., Inc., Kenilworth, NJ 07033
- Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM 87545,, Santa Fe Institute, Santa Fe, NM 87501,
- Publication Date:
- Research Org.:
- Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Santa Fe Inst. (SFI), Santa Fe, NM (United States); Univ. of Pennsylvania, Philadelphia, PA (United States)
- Sponsoring Org.:
- USDOE; National Inst. of Health (NIH) (United States)
- OSTI Identifier:
- 1459484
- Alternate Identifier(s):
- OSTI ID: 1625021
- Grant/Contract Number:
- AC52-06NA25396; R01-OD011095; R01-AI028433; R01-AI078881; R01-AI116868; U19-AI088791; P30-AI45008
- Resource Type:
- Published Article
- Journal Name:
- Proceedings of the National Academy of Sciences of the United States of America
- Additional Journal Information:
- Journal Name: Proceedings of the National Academy of Sciences of the United States of America Journal Volume: 115 Journal Issue: 30; Journal ID: ISSN 0027-8424
- Publisher:
- Proceedings of the National Academy of Sciences
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES; virus evolution; virus persistence; hepatitis C virus; phylodynamic modeling; mathematical modeling
Citation Formats
Ke, Ruian, Li, Hui, Wang, Shuyi, Ding, Wenge, Ribeiro, Ruy M., Giorgi, Elena E., Bhattacharya, Tanmoy, Barnard, Richard J. O., Hahn, Beatrice H., Shaw, George M., and Perelson, Alan S. Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence. United States: N. p., 2018.
Web. doi:10.1073/pnas.1805267115.
Ke, Ruian, Li, Hui, Wang, Shuyi, Ding, Wenge, Ribeiro, Ruy M., Giorgi, Elena E., Bhattacharya, Tanmoy, Barnard, Richard J. O., Hahn, Beatrice H., Shaw, George M., & Perelson, Alan S. Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence. United States. https://doi.org/10.1073/pnas.1805267115
Ke, Ruian, Li, Hui, Wang, Shuyi, Ding, Wenge, Ribeiro, Ruy M., Giorgi, Elena E., Bhattacharya, Tanmoy, Barnard, Richard J. O., Hahn, Beatrice H., Shaw, George M., and Perelson, Alan S. Mon .
"Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence". United States. https://doi.org/10.1073/pnas.1805267115.
@article{osti_1459484,
title = {Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence},
author = {Ke, Ruian and Li, Hui and Wang, Shuyi and Ding, Wenge and Ribeiro, Ruy M. and Giorgi, Elena E. and Bhattacharya, Tanmoy and Barnard, Richard J. O. and Hahn, Beatrice H. and Shaw, George M. and Perelson, Alan S.},
abstractNote = {RNA viruses exist as a genetically diverse quasispecies with extraordinary ability to adapt to abrupt changes in the host environment. However, the molecular mechanisms that contribute to their rapid adaptation and persistence in vivo are not well studied. Here, we probe hepatitis C virus (HCV) persistence by analyzing clinical samples taken from subjects who were treated with a second-generation HCV protease inhibitor. Frequent longitudinal viral load determinations and large-scale single-genome sequence analyses revealed rapid antiviral resistance development, and surprisingly, dynamic turnover of dominant drug-resistant mutant populations long after treatment cessation. We fitted mathematical models to both the viral load and the viral sequencing data, and the results provided strong support for the critical roles that superinfection and cure of infected cells play in facilitating the rapid turnover and persistence of viral populations. More broadly, our results highlight the importance of considering viral dynamics and competition at the intracellular level in understanding rapid viral adaptation. Thus, we propose a theoretical framework integrating viral and molecular mechanisms to explain rapid viral evolution, resistance, and persistence despite antiviral treatment and host immune responses.},
doi = {10.1073/pnas.1805267115},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
number = 30,
volume = 115,
place = {United States},
year = {2018},
month = {7}
}
https://doi.org/10.1073/pnas.1805267115
Web of Science
Works referenced in this record:
Unifying the Epidemiological and Evolutionary Dynamics of Pathogens
journal, January 2004
- Grenfell, B. T.
- Science, Vol. 303, Issue 5656
Analysis of Hepatitis C Virus Superinfection Exclusion by Using Novel Fluorochrome Gene-Tagged Viral Genomes
journal, February 2007
- Schaller, T.; Appel, N.; Koutsoudakis, G.
- Journal of Virology, Vol. 81, Issue 9
Characterization of Hepatitis C Virus Recombination in Cameroon by Use of Nonspecific Next-Generation Sequencing
journal, July 2015
- Iles, James C.; Njouom, Richard; Foupouapouognigni, Yacouba
- Journal of Clinical Microbiology, Vol. 53, Issue 10
The role of mutational robustness in RNA virus evolution
journal, March 2013
- Lauring, Adam S.; Frydman, Judith; Andino, Raul
- Nature Reviews Microbiology, Vol. 11, Issue 5
Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial
journal, March 2015
- Sulkowski, Mark; Hezode, Christophe; Gerstoft, Jan
- The Lancet, Vol. 385, Issue 9973
Superinfection Exclusion in Cells Infected with Hepatitis C Virus
journal, February 2007
- Tscherne, D. M.; Evans, M. J.; von Hahn, T.
- Journal of Virology, Vol. 81, Issue 8
A Comprehensive Hepatitis C Viral Kinetic Model Explaining Cure
journal, May 2010
- Snoeck, E.; Chanu, P.; Lavielle, M.
- Clinical Pharmacology & Therapeutics, Vol. 87, Issue 6
Influence of Viral Replication Mechanisms on Within-Host Evolutionary Dynamics: Influence of Viral Replication Mechanisms on Within-Host Evolutionary Dynamics
journal, June 2012
- Loverdo, Claude; Park, Miran; Schreiber, Sebastian J.
- Evolution, Vol. 66, Issue 11
Evasion of Superinfection Exclusion and Elimination of Primary Viral RNA by an Adapted Strain of Hepatitis C Virus
journal, October 2013
- Webster, B.; Ott, M.; Greene, W. C.
- Journal of Virology, Vol. 87, Issue 24
Viral Quasispecies Evolution
journal, June 2012
- Domingo, E.; Sheldon, J.; Perales, C.
- Microbiology and Molecular Biology Reviews, Vol. 76, Issue 2
Second-phase hepatitis C virus RNA decline during telaprevir-based therapy increases with drug effectiveness: Implications for treatment duration
journal, May 2011
- Guedj, Jeremie; Perelson, Alan S.
- Hepatology, Vol. 53, Issue 6
Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver
journal, April 2014
- Wieland, Stefan; Makowska, Zuzanna; Campana, Benedetta
- Hepatology, Vol. 59, Issue 6
Mathematical Analysis of HIV-1 Dynamics in Vivo
journal, January 1999
- Perelson, Alan S.; Nelson, Patrick W.
- SIAM Review, Vol. 41, Issue 1
The role of cells refractory to productive infection in acute hepatitis B viral dynamics
journal, March 2007
- Ciupe, S. M.; Ribeiro, R. M.; Nelson, P. W.
- Proceedings of the National Academy of Sciences, Vol. 104, Issue 12
Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations
journal, December 2011
- Fridell, Robert A.; Wang, Chunfu; Sun, Jin-Hua
- Hepatology, Vol. 54, Issue 6
MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants
journal, May 2012
- Summa, Vincenzo; Ludmerer, Steven W.; McCauley, John A.
- Antimicrobial Agents and Chemotherapy, Vol. 56, Issue 8
Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus
journal, May 2010
- Rong, L.; Dahari, H.; Ribeiro, R. M.
- Science Translational Medicine, Vol. 2, Issue 30
Vacated niches, competitive release and the community ecology of pathogen eradication
journal, August 2013
- Lloyd-Smith, James O.
- Philosophical Transactions of the Royal Society B: Biological Sciences, Vol. 368, Issue 1623
In vitro combinations containing Tegobuvir are highly efficient in curing cells from HCV replicon and in delaying/preventing the development of drug resistance
journal, August 2015
- Vliegen, Inge; Paeshuyse, Jan; Zhong, Weidong
- Antiviral Research, Vol. 120
Modelling clinical data shows active tissue concentration of daclatasvir is 10-fold lower than its plasma concentration
journal, October 2013
- Ke, R.; Loverdo, C.; Qi, H.
- Journal of Antimicrobial Chemotherapy, Vol. 69, Issue 3
Elucidation of Hepatitis C Virus Transmission and Early Diversification by Single Genome Sequencing
journal, August 2012
- Li, Hui; Stoddard, Mark B.; Wang, Shuyi
- PLoS Pathogens, Vol. 8, Issue 8
Quantifying the Diversification of Hepatitis C Virus (HCV) during Primary Infection: Estimates of the In Vivo Mutation Rate
journal, August 2012
- Ribeiro, Ruy M.; Li, Hui; Wang, Shuyi
- PLoS Pathogens, Vol. 8, Issue 8
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
journal, May 2008
- Keele, B. F.; Giorgi, E. E.; Salazar-Gonzalez, J. F.
- Proceedings of the National Academy of Sciences, Vol. 105, Issue 21
Inferring Viral Dynamics in Chronically HCV Infected Patients from the Spatial Distribution of Infected Hepatocytes
journal, November 2014
- Graw, Frederik; Balagopal, Ashwin; Kandathil, Abraham J.
- PLoS Computational Biology, Vol. 10, Issue 11
A Multi-Variant, Viral Dynamic Model of Genotype 1 HCV to Assess the in vivo Evolution of Protease-Inhibitor Resistant Variants
journal, April 2010
- Adiwijaya, Bambang S.; Herrmann, Eva; Hare, Brian
- PLoS Computational Biology, Vol. 6, Issue 4
Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs
journal, December 2002
- Randall, G.; Grakoui, A.; Rice, C. M.
- Proceedings of the National Academy of Sciences, Vol. 100, Issue 1
Combination of a Hepatitis C Virus NS3-NS4A Protease Inhibitor and Alpha Interferon Synergistically Inhibits Viral RNA Replication and Facilitates Viral RNA Clearance in Replicon Cells
journal, November 2004
- Lin, K.; Kwong, A. D.; Lin, C.
- Antimicrobial Agents and Chemotherapy, Vol. 48, Issue 12
Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture
journal, March 2003
- Lohmann, V.; Hoffmann, S.; Herian, U.
- Journal of Virology, Vol. 77, Issue 5
Low Dynamic State of Viral Competition in a Chronic Avian Hepadnavirus Infection
journal, June 2000
- Zhang, Y. -Y.; Summers, J.
- Journal of Virology, Vol. 74, Issue 11
Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study
journal, October 2016
- Lau, George; Benhamou, Yves; Chen, Guofeng
- The Lancet Gastroenterology & Hepatology, Vol. 1, Issue 2
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
journal, December 2002
- Blight, K. J.; McKeating, J. A.; Rice, C. M.
- Journal of Virology, Vol. 76, Issue 24
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
journal, December 2015
- Feld, Jordan J.; Jacobson, Ira M.; Hézode, Christophe
- New England Journal of Medicine, Vol. 373, Issue 27
Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance
journal, May 2017
- Bailey, Justin R.; Flyak, Andrew I.; Cohen, Valerie J.
- JCI Insight, Vol. 2, Issue 9
Protease Inhibitor–Resistant Hepatitis C Virus Mutants With Reduced Fitness From Impaired Production of Infectious Virus
journal, February 2011
- Shimakami, Tetsuro; Welsch, Christoph; Yamane, Daisuke
- Gastroenterology, Vol. 140, Issue 2
Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirin
journal, December 2014
- Hedskog, Charlotte; Doehle, Brian; Chodavarapu, Krishna
- Hepatology, Vol. 61, Issue 2
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon- Therapy
journal, October 1998
- Neumann, A. U.
- Science, Vol. 282, Issue 5386
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life
journal, February 2013
- Guedj, J.; Dahari, H.; Rong, L.
- Proceedings of the National Academy of Sciences, Vol. 110, Issue 10
Analysis of Hepatitis C Virus Decline during Treatment with the Protease Inhibitor Danoprevir Using a Multiscale Model
journal, March 2013
- Rong, Libin; Guedj, Jeremie; Dahari, Harel
- PLoS Computational Biology, Vol. 9, Issue 3
Pre–existence and emergence of drug resistance in HIV–1 infection
journal, May 1997
- Sebastian, Bonhoeffer; Martin, A. Nowak
- Proceedings of the Royal Society of London. Series B: Biological Sciences, Vol. 264, Issue 1382
Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics
journal, December 2010
- Guedj, J.; Neumann, A. U.
- Journal of Theoretical Biology, Vol. 267, Issue 3
Antibody neutralization and escape by HIV-1
journal, March 2003
- Wei, Xiping; Decker, Julie M.; Wang, Shuyi
- Nature, Vol. 422, Issue 6929
Genetic recombination of the hepatitis C virus: clinical implications: Impacts of HCV recombination
journal, September 2010
- Morel, V.; Fournier, C.; François, C.
- Journal of Viral Hepatitis, Vol. 18, Issue 2
Quantification of Hepatitis C Virus Cell-to-Cell Spread Using a Stochastic Modeling Approach
journal, April 2015
- Graw, Frederik; Martin, Danyelle N.; Perelson, Alan S.
- Journal of Virology, Vol. 89, Issue 13
Avoiding the void: cell-to-cell spread of human viruses
journal, November 2008
- Sattentau, Quentin
- Nature Reviews Microbiology, Vol. 6, Issue 11
The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes
journal, December 2001
- Erickson, Ann L.; Kimura, Yoichi; Igarashi, Suzu
- Immunity, Vol. 15, Issue 6
Modeling Viral Spread
journal, September 2016
- Graw, Frederik; Perelson, Alan S.
- Annual Review of Virology, Vol. 3, Issue 1
Rational Design and Adaptive Management of Combination Therapies for Hepatitis C Virus Infection
journal, June 2015
- Ke, Ruian; Loverdo, Claude; Qi, Hangfei
- PLOS Computational Biology, Vol. 11, Issue 6
A perspective on modelling hepatitis C virus infection: A perspective on modelling HCV infection
journal, August 2010
- Guedj, J.; Rong, L.; Dahari, H.
- Journal of Viral Hepatitis, Vol. 17, Issue 12
Beneficial Mutation–Selection Balance and the Effect of Linkage on Positive Selection
journal, May 2007
- Desai, Michael M.; Fisher, Daniel S.
- Genetics, Vol. 176, Issue 3
Pre-existence and emergence of drug resistance in a generalized model of intra-host viral dynamics
journal, December 2012
- Alexander, Helen K.; Bonhoeffer, Sebastian
- Epidemics, Vol. 4, Issue 4
Virologic Resistance Analysis From a Phase 2 Study of MK-5172 Combined With Pegylated Interferon/Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection
journal, September 2014
- Howe, Anita Y. M.; Black, Stuart; Curry, Stephanie
- Clinical Infectious Diseases, Vol. 59, Issue 12
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
journal, February 2015
- Stoddard, Mark B.; Li, Hui; Wang, Shuyi
- mBio, Vol. 6, Issue 2
Evolutionary Analysis of Human Immunodeficiency Virus Type 1 Therapies Based on Conditionally Replicating Vectors
journal, October 2012
- Ke, Ruian; Lloyd-Smith, James O.
- PLoS Computational Biology, Vol. 8, Issue 10
Influenza A Virus Uses Intercellular Connections To Spread to Neighboring Cells
journal, November 2014
- Roberts, Kari L.; Manicassamy, Balaji; Lamb, Robert A.
- Journal of Virology, Vol. 89, Issue 3
Antiretroviral dynamics determines HIV evolution and predicts therapy outcome
journal, September 2012
- Rosenbloom, Daniel I. S.; Hill, Alison L.; Rabi, S. Alireza
- Nature Medicine, Vol. 18, Issue 9
Use of Laser Capture Microdissection to Map Hepatitis C Virus–Positive Hepatocytes in Human Liver
journal, December 2013
- Kandathil, Abraham J.; Graw, Frederik; Quinn, Jeffrey
- Gastroenterology, Vol. 145, Issue 6
Global control of hepatitis C: where challenge meets opportunity
journal, July 2013
- Thomas, David L.
- Nature Medicine, Vol. 19, Issue 7
Origin and Evolution of the Unique Hepatitis C Virus Circulating Recombinant Form 2k/1b
journal, November 2011
- Raghwani, J.; Thomas, X. V.; Koekkoek, S. M.
- Journal of Virology, Vol. 86, Issue 4